Cargando…

Genetic Interactions Explain Variance in Cingulate Amyloid Burden: An AV-45 PET Genome-Wide Association and Interaction Study in the ADNI Cohort

Alzheimer's disease (AD) is the most common neurodegenerative disorder. Using discrete disease status as the phenotype and computing statistics at the single marker level may not be able to address the underlying biological interactions that contribute to disease mechanism and may contribute to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jin, Zhang, Qiushi, Chen, Feng, Yan, Jingwen, Kim, Sungeun, Wang, Lei, Feng, Weixing, Saykin, Andrew J., Liang, Hong, Shen, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573220/ https://www.ncbi.nlm.nih.gov/pubmed/26421299 http://dx.doi.org/10.1155/2015/647389

Ejemplares similares

Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort
por: Cong, Wang, et al.
Publicado: (2017)

Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort
por: Swaminathan, Shanker, et al.
Publicado: (2011)

Network-based analysis of genetic variants associated with hippocampal volume in Alzheimer’s disease: a study of ADNI cohorts
por: Song, Ailin, et al.
Publicado: (2016)

β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3
por: Bourgeat, Pierrick, et al.
Publicado: (2022)

Using PET with (18)F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment
por: Camus, V., et al.
Publicado: (2012)

Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study
por: Swaminathan, Shanker, et al.
Publicado: (2011)

Recurrent interactions can explain the variance in single trial responses
por: Kotekal, Subhodh, et al.
Publicado: (2020)

Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
por: Risacher, Shannon L, et al.
Publicado: (2009)

The Pattern of Brain Amyloid Load in Posterior Cortical Atrophy Using (18)F-AV45: Is Amyloid the Principal Actor in the Disease?
por: Beaufils, Emilie, et al.
Publicado: (2014)

Development and validation of language and visuospatial composite scores in ADNI
por: Choi, Seo‐Eun, et al.
Publicado: (2020)

Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database
por: Ben Bouallègue, Fayçal, et al.
Publicado: (2017)

Voxel-based statistical analysis and quantification of amyloid PET in the Japanese Alzheimer’s disease neuroimaging initiative (J-ADNI) multi-center study
por: Akamatsu, Go, et al.
Publicado: (2019)

Genome-Wide Epistasis Study of Cerebrospinal Fluid Hyperphosphorylated Tau in ADNI Cohort
por: Chen, Dandan, et al.
Publicado: (2023)

Targeted metabolomics and medication classification data from participants in the ADNI1 cohort
por: St John-Williams, Lisa, et al.
Publicado: (2017)

Classification of Alzheimer's and MCI Patients from Semantically Parcelled PET Images: A Comparison between AV45 and FDG-PET
por: Nozadi, Seyed Hossein, et al.
Publicado: (2018)

Harnessing peripheral DNA methylation differences in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease
por: Vasanthakumar, Aparna, et al.
Publicado: (2020)

Mapping the Genetic Variation of Regional Brain Volumes as Explained by All Common SNPs from the ADNI Study
por: Bryant, Christopher, et al.
Publicado: (2013)

Cryptic Sites in Tau Fibrils Explain the Preferential Binding of the AV-1451 PET Tracer toward Alzheimer’s Tauopathy
por: Murugan, N. Arul, et al.
Publicado: (2021)

A voxel-based morphometry comparison of the 3.0T ADNI-1 and ADNI-2 volumetric MRI protocols
por: Brunton, Simon, et al.
Publicado: (2015)

Evaluation of the early-phase [(18)F]AV45 PET as an optimal surrogate of [(18)F]FDG PET in ageing and Alzheimer’s clinical syndrome
por: Vanhoutte, Matthieu, et al.
Publicado: (2021)

Optimization of Automatic Synthesis and Separation of [(18)F] AV-45 and Quality Control
por: Zhang, Qi-Zhou, et al.
Publicado: (2022)

The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI‐3 updates and global perspectives
por: Weber, Christopher J., et al.
Publicado: (2021)

Imaging Aβ and tau in early stage Alzheimer’s disease with [(18)F]AV45 and [(18)F]AV1451
por: Firouzian, Azadeh, et al.
Publicado: (2018)

Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo
por: Saint-Aubert, L., et al.
Publicado: (2013)

Imago Mundi, Imago AD, Imago ADNI
por: Villemagne, Victor L, et al.
Publicado: (2014)

Identifying progressive imaging genetic patterns via multi-task sparse canonical correlation analysis: a longitudinal study of the ADNI cohort
por: Du, Lei, et al.
Publicado: (2019)

An autoradiographic evaluation of AV-1451 Tau PET in dementia
por: Lowe, Val J., et al.
Publicado: (2016)

Transcriptome-guided amyloid imaging genetic analysis via a novel structured sparse learning algorithm
por: Yan, Jingwen, et al.
Publicado: (2014)

Brain network alterations in individuals with and without mild cognitive impairment: parallel independent component analysis of AV1451 and AV45 positron emission tomography
por: Li, Yuan, et al.
Publicado: (2019)

Targeting Amyloids with [(18)F]AV-45 for Medullary Thyroid Carcinoma Positron Emission Tomography/Computed Tomography Imaging: A Pilot Clinical Study
por: Li, Chun, et al.
Publicado: (2022)

Regional Amyloid Deposition in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Evaluated by [(18)F]AV-45 Positron Emission Tomography in Chinese Population
por: Huang, Kuo-Lun, et al.
Publicado: (2013)

Bayesian estimation of explained variance in ANOVA designs
por: Marsman, Maarten, et al.
Publicado: (2019)

Clinical and multimodal biomarker correlates of ADNI neuropathological findings
por: Toledo, Jon B, et al.
Publicado: (2013)

Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts
por: St. John-Williams, Lisa, et al.
Publicado: (2019)

Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy
por: Smith, Ruben, et al.
Publicado: (2016)

Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort
por: Liu, Yi, et al.
Publicado: (2022)

PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with (18)F-AV-133 (florbenazine) in patients with Alzheimer’s disease and Lewy body disorders
por: Siderowf, Andrew, et al.
Publicado: (2014)

AV monografías = AV monographs.
Publicado: (1995)

Factors explaining variance in perceived pain in women with fibromyalgia
por: Malt, Eva Albertsen, et al.
Publicado: (2002)

The unbiased estimation of the fraction of variance explained by a model
por: Pospisil, Dean A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mfmebtascsolkedcnms7vkubvj